Skip to Content

Dengue Tetravalent Vaccine (Live, Attenuated) Takeda

Licence status
Authorised: 05/12/2022
Active substances
Dengue virus serotype 1# (live, attenuated), Dengue virus, serotype 2, live, attenuated, Dengue virus serotype 3# (live, attenuated), Dengue virus serotype 4# (live, attenuated)
Dosage Form
Powder and solvent for solution for injection
Licence number
EU/1/22/1699/002
Licence holder
Takeda GmbH

Licence information

ATC code
J07BX04 Dengue virus vaccine
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
05/12/2022